Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Neogenomics Inc (NEO)

Neogenomics Inc (NEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,971,625
  • Shares Outstanding, K 128,361
  • Annual Sales, $ 591,640 K
  • Annual Income, $ -87,970 K
  • EBIT $ -92 M
  • EBITDA $ -17 M
  • 60-Month Beta 1.19
  • Price/Sales 3.33
  • Price/Cash Flow 54.41
  • Price/Book 2.17

Options Overview Details

View History
  • Implied Volatility 37.15% ( -2.17%)
  • Historical Volatility 35.20%
  • IV Percentile 4%
  • IV Rank 13.92%
  • IV High 83.20% on 04/11/24
  • IV Low 29.71% on 11/14/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 455
  • Volume Avg (30-Day) 560
  • Put/Call OI Ratio 0.28
  • Today's Open Interest 10,987
  • Open Int (30-Day) 14,654

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.04
  • Number of Estimates 5
  • High Estimate -0.04
  • Low Estimate -0.05
  • Prior Year -0.02
  • Growth Rate Est. (year over year) -100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
12.85 +18.91%
on 10/23/24
16.60 -7.94%
on 11/14/24
+2.15 (+16.37%)
since 10/21/24
3-Month
12.77 +19.66%
on 10/10/24
16.97 -9.96%
on 08/23/24
-1.15 (-7.00%)
since 08/21/24
52-Week
12.77 +19.66%
on 10/10/24
21.22 -27.99%
on 12/22/23
-3.90 (-20.33%)
since 11/21/23

Most Recent Stories

More News
NeoGenomics: Q3 Earnings Snapshot

NeoGenomics: Q3 Earnings Snapshot

NEO : 15.47 (+0.72%)
Humacyte’s $30 Million Stock Offering Fuels Growth Despite Insider Concerns

Benchmark analyst Bruce Jackson maintained a Buy rating on Humacyte (HUMA) with a price target of $15.00, suggesting a significant upside for the company’s stock. Humacyte shares closed at $5.39 yesterday,...

HUMA : 4.47 (+1.36%)
EXAS : 53.54 (+1.59%)
NEO : 15.47 (+0.72%)
NeoGenomics: Q2 Earnings Snapshot

NeoGenomics: Q2 Earnings Snapshot

NEO : 15.47 (+0.72%)
NeoGenomics: Q1 Earnings Snapshot

NeoGenomics: Q1 Earnings Snapshot

NEO : 15.47 (+0.72%)
NeoGenomics: Q4 Earnings Snapshot

NeoGenomics: Q4 Earnings Snapshot

NEO : 15.47 (+0.72%)
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030

EQNX::TICKER_START (OTCQB:TDSGF),(TSXV:TELO),(NYSE:BMY),(NYSE:TMO),(NASDAQ:NTRA),(NASDAQ:NEO) EQNX::TICKER_END

TDSGF : 0.0810 (-11.18%)
TELO.VN : 0.120 (+4.35%)
BMY : 58.19 (+0.54%)
TMO : 514.42 (+0.31%)
NTRA : 169.84 (+1.17%)
NEO : 15.47 (+0.72%)
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030

TDSGF : 0.0810 (-11.18%)
TELO.VN : 0.120 (+4.35%)
BMY : 58.19 (+0.54%)
TMO : 514.42 (+0.31%)
NTRA : 169.84 (+1.17%)
NEO : 15.47 (+0.72%)
Altice USA, PENN Entertainment rise; Hess, NeoGenomics fall, Thursday, 12/28/2023

Stocks that traded heavily or had substantial price changes on Thursday: Altice USA, PENN Entertainment rise; Hess, NeoGenomics fall

ABX.TO : 25.19 (+0.64%)
BABA : 85.80 (-1.12%)
AMZN : 198.28 (-2.27%)
HES : 148.81 (+0.91%)
ATUS : 2.55 (+5.37%)
AAPL : 229.27 (+0.12%)
NEO : 15.47 (+0.72%)
NeoGenomics to Present New Data at San Antonio Breast Cancer Symposium Highlighting Utility of RaDaR for Therapy Response

FT. MYERS, FL / ACCESSWIRE / December 5, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading oncology testing services company, today announced new data highlighting its RaDaR® assay for minimal residual...

NEO : 15.47 (+0.72%)
NeoGenomics to Participate at the Piper Sandler 35th Annual Healthcare Conference

FT. MYERS, FL / ACCESSWIRE / November 14, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading oncology testing services company, today announced the company will participate in the upcoming Piper Sandler...

NEO : 15.47 (+0.72%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory that specializes in cancer genetics diagnostic testing, the fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluorescence in-situ hybridization, flow cytometry, morphology...

See More

Key Turning Points

3rd Resistance Point 16.00
2nd Resistance Point 15.75
1st Resistance Point 15.55
Last Price 15.47
1st Support Level 15.10
2nd Support Level 14.85
3rd Support Level 14.65

See More

52-Week High 21.22
Fibonacci 61.8% 17.99
Fibonacci 50% 16.99
Fibonacci 38.2% 16.00
Last Price 15.47
52-Week Low 12.77

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar